119 related articles for article (PubMed ID: 26111959)
21. A facile approach to functionalizing cell membrane-coated nanoparticles with neurotoxin-derived peptide for brain-targeted drug delivery.
Chai Z; Hu X; Wei X; Zhan C; Lu L; Jiang K; Su B; Ruan H; Ran D; Fang RH; Zhang L; Lu W
J Control Release; 2017 Oct; 264():102-111. PubMed ID: 28842313
[TBL] [Abstract][Full Text] [Related]
22. Cyclic RGDyK conjugation facilitates intracellular drug delivery of polymeric micelles to integrin-overexpressing tumor cells and neovasculature.
Yin J; Li Z; Yang T; Wang J; Zhang X; Zhang Q
J Drug Target; 2011 Jan; 19(1):25-36. PubMed ID: 20233083
[TBL] [Abstract][Full Text] [Related]
23. Size-dependent radiosensitization of PEG-coated gold nanoparticles for cancer radiation therapy.
Zhang XD; Wu D; Shen X; Chen J; Sun YM; Liu PX; Liang XJ
Biomaterials; 2012 Sep; 33(27):6408-19. PubMed ID: 22681980
[TBL] [Abstract][Full Text] [Related]
24. Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR dye: In vitro and in vivo evaluation.
Choi J; Rustique E; Henry M; Guidetti M; Josserand V; Sancey L; Boutet J; Coll JL
Int J Pharm; 2017 Nov; 532(2):677-685. PubMed ID: 28279737
[TBL] [Abstract][Full Text] [Related]
25. Manipulation of in vitro angiogenesis using peptide-coated gold nanoparticles.
Bartczak D; Muskens OL; Sanchez-Elsner T; Kanaras AG; Millar TM
ACS Nano; 2013 Jun; 7(6):5628-36. PubMed ID: 23713973
[TBL] [Abstract][Full Text] [Related]
26. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands.
Huang X; Peng X; Wang Y; Wang Y; Shin DM; El-Sayed MA; Nie S
ACS Nano; 2010 Oct; 4(10):5887-96. PubMed ID: 20863096
[TBL] [Abstract][Full Text] [Related]
27. Conjugation of peptides to the passivation shell of gold nanoparticles for targeting of cell-surface receptors.
Maus L; Dick O; Bading H; Spatz JP; Fiammengo R
ACS Nano; 2010 Nov; 4(11):6617-28. PubMed ID: 20939520
[TBL] [Abstract][Full Text] [Related]
28. Cellular uptake and fate of PEGylated gold nanoparticles is dependent on both cell-penetration peptides and particle size.
Oh E; Delehanty JB; Sapsford KE; Susumu K; Goswami R; Blanco-Canosa JB; Dawson PE; Granek J; Shoff M; Zhang Q; Goering PL; Huston A; Medintz IL
ACS Nano; 2011 Aug; 5(8):6434-48. PubMed ID: 21774456
[TBL] [Abstract][Full Text] [Related]
29. pH-responsive gold nanoparticles-in-liposome hybrid nanostructures for enhanced systemic tumor delivery.
Nam J; Ha YS; Hwang S; Lee W; Song J; Yoo J; Kim S
Nanoscale; 2013 Nov; 5(21):10175-8. PubMed ID: 24057056
[TBL] [Abstract][Full Text] [Related]
30. Melanocortin 1 Receptor Targeted Imaging of Melanoma With Gold Nanocages and Positron Emission Tomography.
Zhao Y; Pang B; Detering L; Luehmann H; Yang M; Black K; Sultan D; Xia Y; Liu Y
Mol Imaging; 2018; 17():1536012118775827. PubMed ID: 29873290
[TBL] [Abstract][Full Text] [Related]
31. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size.
Sonavane G; Tomoda K; Makino K
Colloids Surf B Biointerfaces; 2008 Oct; 66(2):274-80. PubMed ID: 18722754
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of Gold Nanoparticle: Peptide-Drug Conjugates for Targeted Drug Delivery.
Kalishwaralal K; Luboshits G; Firer MA
Methods Mol Biol; 2020; 2059():145-154. PubMed ID: 31435919
[TBL] [Abstract][Full Text] [Related]
33. A mitochondria-targeting gold-peptide nanoassembly for enhanced cancer-cell killing.
Ma X; Wang X; Zhou M; Fei H
Adv Healthc Mater; 2013 Dec; 2(12):1638-43. PubMed ID: 23657942
[TBL] [Abstract][Full Text] [Related]
34. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models.
Balogh L; Nigavekar SS; Nair BM; Lesniak W; Zhang C; Sung LY; Kariapper MS; El-Jawahri A; Llanes M; Bolton B; Mamou F; Tan W; Hutson A; Minc L; Khan MK
Nanomedicine; 2007 Dec; 3(4):281-96. PubMed ID: 17962085
[TBL] [Abstract][Full Text] [Related]
35. Effect of molecular size of pegylated peptide on the pharmacokinetics and tumor targeting in lymphoma-bearing mice.
DeNardo SJ; Yao Z; Lam KS; Song A; Burke PA; Mirick GR; Lamborn KR; O'Donnell RT; DeNardo GL
Clin Cancer Res; 2003 Sep; 9(10 Pt 2):3854S-64S. PubMed ID: 14506183
[TBL] [Abstract][Full Text] [Related]
36. Penetration of pegylated gold nanoparticles through rat placental barrier.
Tsyganova NA; Khairullin RM; Terentyuk GS; Khlebtsov BN; Bogatyrev VA; Dykman LA; Erykov SN; Khlebtsov NG
Bull Exp Biol Med; 2014 Jul; 157(3):383-5. PubMed ID: 25065320
[TBL] [Abstract][Full Text] [Related]
37. Cellular uptake of gold nanoparticles directly cross-linked with carrier peptides by osteosarcoma cells.
Mandal D; Maran A; Yaszemski MJ; Bolander ME; Sarkar G
J Mater Sci Mater Med; 2009 Jan; 20(1):347-50. PubMed ID: 18807262
[TBL] [Abstract][Full Text] [Related]
38. Local Effects on Airway Inflammation and Systemic Uptake of 5 nm PEGylated and Citrated Gold Nanoparticles in Asthmatic Mice.
Omlor AJ; Le DD; Schlicker J; Hannig M; Ewen R; Heck S; Herr C; Kraegeloh A; Hein C; Kautenburger R; Kickelbick G; Bals R; Nguyen J; Dinh QT
Small; 2017 Mar; 13(10):. PubMed ID: 28009478
[TBL] [Abstract][Full Text] [Related]
39. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY
Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of PEGylated gold nanostars and bipyramids for intracellular uptake.
Navarro JR; Manchon D; Lerouge F; Blanchard NP; Marotte S; Leverrier Y; Marvel J; Chaput F; Micouin G; Gabudean AM; Mosset A; Cottancin E; Baldeck PL; Kamada K; Parola S
Nanotechnology; 2012 Nov; 23(46):465602. PubMed ID: 23095344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
